CRISPR Therapeutics · NASDAQ: CRSP · Biotechnology
Over the past week, CRISPR Therapeutics (CRSP) racked up about 42 mentions across Reddit, X and news, and the read is an Adanos Hold. The crowd averages 50% bullish but is deeply split: News runs 100% bullish while Reddit sits at just 17%. Wall Street is more constructive, with 15 of 25 analysts rating CRSP a buy.
There is little buzz around CRSP this week and little agreement on direction, which is why it reads as a Hold.
Wall Street’s 60% buy share sits next to a crowd that ranges from Reddit at 17% to News at 100%. No other tracker puts the two side by side.
Across 25 analysts the consensus is a Strong Buy: 15 buy calls against 0 sell, with an average 12-month price target of $84.70.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits right on the neutral line, momentum is improving and the 3 sources disagree sharply, so the read is Hold rather than a clear buy or sell.
Analysts sit 10 points above the crowd average of 50%, the professionals are more constructive than retail. The split is inside the crowd: News reads 100% bullish while Reddit sits at 17%, a 83-point spread that single-source trackers miss.
Over the 30-day window, CRISPR Therapeutics (CRSP) buzz held subdued around 32.2 while the price drifted up 1.4% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 1.8M shares. Updated Jul 13, 2026. Over the last 7 trading days, CRSP lost 4.1%. Buzz activity in the recent week averaged 35.2 and was variable, swinging between 25.6 and 54.1. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 14 of the 18 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Buzz, bullish share, the loudest item and the positive / neutral / negative split for every tracked source over the last 7 days.
No Polymarket data for this stock this week.
Query sentiment for CRSP and 1000+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live CRSP sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Jul 13, 2026.
Based on aggregated sentiment from Reddit, X and News sources, CRISPR Therapeutics (CRSP) currently carries an Adanos hold signal with 60/100 conviction. The current cross-source average reads 50% bullish across 3 active sources. Those sources contribute 42 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around CRISPR Therapeutics (CRSP) is fairly quiet with 6 mentions across 19 tracked subreddits. The tone is 17% bullish with stable 3-day activity momentum, suggesting steady attention.
CRISPR Therapeutics (CRSP) sentiment is mixed across all 3 tracked sources. X reads 34% bullish, News reads 100% bullish and reddit coverage is the most negative at 17% bullish. The combined signal points to broad mixed pressure with 60/100 conviction.
Social sentiment data shows consistently mixed discussion around CRISPR Therapeutics (CRSP). All 3 tracked sources lean in different directions, with reddit being the most bearish at 17% bullish. 3-day activity momentum is rising across X and News. The hold signal carries 60/100 conviction.
X is the dominant discussion channel with 29 mentions (69% of total volume). News contributes 7 mentions and Reddit contributes 6 mentions. Sentiment is mixed across all sources, while x and news show rising 3-day activity.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. CRSP's hold signal at 60/100 conviction reflects consistently mixed sentiment across multiple platforms. It is a research shortcut, not financial advice.
The CRSP sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
These stocks share a comparable sentiment profile to CRISPR Therapeutics with similar bullish ratios, signal direction and discussion volume. All 6 peers carry hold signals, pointing to broad mixed pressure rather than an CRSP-specific issue.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key